8.03  -0.35 (-4.18%)		10-01 16:00
Open: 8.5 High: 8.5 Volume: 700,734		Pre. Close: 8.38 Low: 7.91 Market Cap: 674(M)

Short term
Mid term
Targets	6-month :	9.84	1-year :	10.48
Resists	First :	8.42	Second :	8.97
Pivot price	8.17
Supports	First :	7.53	Second :	6.26
MAs	MA(5) :	8.3	MA(20) :	8.13
	MA(100) :	6.47	MA(250) :	5.44
MACD	MACD :	0.1	Signal :	0.1
%K %D	K(14,3) :	58.8	D(3) :	67.1
RSI	RSI(14): 49.4
52-week	High :	8.97	Low :	3.75

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ SOPH ] has closed above bottom band by 32.9%. Bollinger Bands are 38.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	8.51 - 8.56	8.56 - 8.59
Low:	7.82 - 7.86	7.86 - 7.89
Close:	7.97 - 8.03	8.03 - 8.09

SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.

Mon, 21 Sep 2026
Officer at SOPHiA GENETICS (NASDAQ: SOPH) lines up 774-share sale after 10b5-1 trades - Stock Titan

Mon, 21 Sep 2026
Planned sale of 422 SOPHiA GENETICS (SOPH) shares disclosed under Rule 144 - Stock Titan

Sun, 20 Sep 2026
SOPHiA GENETICS SA(NasdaqGS: SOPH) added to S&P Global BMI Index - marketscreener.com

Fri, 18 Sep 2026
SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last? - Yahoo Finance

Thu, 17 Sep 2026
SOPHiA GENETICS SA (NASDAQ: SOPH) Executive Menu Philippe Disposes of 5,000 Shares at $7.88 Each - Kalkine Media

Wed, 16 Sep 2026
SOPHiA Genetics: Scaling Phase Begins As U.S. And Pharma Monetization Inflect - Seeking Alpha

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	85 (M)
Shares Float	65 (M)
Held by Insiders	6.7 (%)
Held by Institutions	62.2 (%)
Shares Short	931 (K)
Shares Short P.Month	661 (K)

EPS	-1.16
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.98
Profit Margin	-93.9 %
Operating Margin	-86.1 %
Return on Assets (ttm)	-24.6 %
Return on Equity (ttm)	-101.3 %
Qtrly Rev. Growth	27.2 %
Gross Profit (p.s.)	0.67
Sales Per Share	1.01
EBITDA (p.s.)	-0.85
Qtrly Earnings Growth	0 %
Operating Cash Flow	-40 (M)
Levered Free Cash Flow	-26 (M)

PE Ratio	-6.93
PEG Ratio	0
Price to Book value	8.19
Price to Sales	7.93
Price to Cash Flow	-17.21

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.